Almost all patients who received a new treatment for highly drug-resistant tuberculosis are still clear of the disease two years after a medical trial in South Africa, findings from a long-term study showed Thursday. Read here.
24-month follow-up confirms efficacy of NiX-TB regimen for XDR-TB
Updated: Jun 21, 2021
Comments